Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression

Translational Psychiatry

Volumn 6, Issue 8, 2016, Pages

  Wei, Y B ^a   Liu, J J ^a   Villaescusa, J C ^a   Aberg E ^b   Brene S ^b   Wegener, G ^c,d   Mathe A A ^a   Lavebratt, C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c AARHUS UNIVERSITY   (Denmark)

^d NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

DROSHA PROTEIN, RAT; INTERLEUKIN 6; LIN28A PROTEIN, RAT; MESSENGER RNA; MICRORNA; MIRN98 MICRORNA-98, RAT; MIRNLET7 MICRORNA, RAT; RIBONUCLEASE III; RNA BINDING PROTEIN;

ANIMAL; DEPRESSION; DISEASE MODEL; GENETICS; MALE; METABOLISM; PREFRONTAL CORTEX; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; DEPRESSION; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; MALE; MICRORNAS; PREFRONTAL CORTEX; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE III; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 85012201002     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/TP.2016.136     Document Type: Article

References (69)

1. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 11–38.
2. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24–31.
3. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neu-ropsychopharmacol Biol Psychiatry 2005; 29: 201–217.
4. Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH et al. A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol 2008; 18: 230–233.
5. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446–457.
6. Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 2009; 66: 287–292.
7. Loftis JM, Huckans M, Morasco BJ. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 2010; 37: 519–533.
8. Dantzer R, O'Connor JC, Lawson MA, Kelley KW. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011; 36: 426–436.
9. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46–56.
10. Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ et al. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry 2012; 2: e199.
11. Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J. Higher plasma interleukin-6 (IL-6) level is associated with SSRI-or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 722–726.
12. O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 2007; 41: 326–331.
13. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22: 370–379.
14. Hamer M, Sabia S, Batty GD, Shipley MJ, Tabak AG, Singh-Manoux A et al. Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study. Circulation 2012; 126: 928–933.
15. Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR et al. Exercise for depression. Cochrane Database Syst Rev 2013; 9: CD004366.
16. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogen-esis, function and decay. Nat Rev Genet 2010; 11: 597–610.
17. Mouillet-Richard S, Baudry A, Launay JM, Kellermann O. MicroRNAs and depres-sion. Neurobiol Dis 2012; 46: 272–278.
18. Dwivedi Y. Evidence demonstrating role of microRNAs in the etiopathology of major depression. J Chem Neuroanat 2011; 42: 142–156.
19. Kocerha J, Dwivedi Y, Brennand KJ. Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease. Mol Psychiatry 2015; 20: 677–684.
20. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000; 408: 86–89.
21. Polikepahad S, Knight JM, Naghavi AO, Oplt T, Creighton CJ, Shaw C et al. Proinflammatory role for let-7 microRNAS in experimental asthma. J Biol Chem 2010; 285: 30139–30149.
22. Teng GG, Wang WH, Dai Y, Wang SJ, Chu YX, Li J. Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4. PLoS One 2013; 8: e56709.
23. Kumar M, Ahmad T, Sharma A, Mabalirajan U, Kulshreshtha A, Agrawal A et al. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immunol 2011; 128: 1077–1085 e1071-1010.
24. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009; 139: 693–706.
25. Chandrasekar V, Dreyer JL. microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci 2009; 42: 350–362.
26. He Y, Yang C, Kirkmire CM, Wang ZJ. Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J Neurosci 2010; 30: 10251–10258.
27. Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl EE, Nitsch R et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol 2008; 10: 987–993.
28. Zhao C, Sun G, Li S, Lang MF, Yang S, Li W et al. MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX sig-naling. Proc Natl Acad Sci USA 2010; 107: 1876–1881.
29. Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M. Clinical sig-nificance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 2008; 14: 2334–2340.
30. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA et al. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 2007; 104: 11400–11405.
31. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007; 67: 7713–7722.
32. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009; 41: 843–848.
33. West JA, Viswanathan SR, Yabuuchi A, Cunniff K, Takeuchi A, Park IH et al. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 2009; 460: 909–913.
34. Piskounova E, Polytarchou C, Thornton JE, LaPierre RJ, Pothoulakis C, Hagan JP et al. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechan-isms. Cell 2011; 147: 1066–1079.
35. Michlewski G, Caceres JF. Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat Struct Mol Biol 2010; 17: 1011–1018.
36. Overstreet DH, Friedman E, Mathé AA, Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 2005; 29: 739–759.
37. Overstreet DH, Wegener G. The flinders sensitive line rat model of depression--25 years and still producing. Pharmacol Rev 2013; 65: 143–155.
38. Melas PA, Rogdaki M, Lennartsson A, Bjork K, Qi H, Witasp A et al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol 2012; 15: 669–679.
39. Wei Y, Melas PA, Wegener G, Mathe AA, Lavebratt C. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. Int J Neuropsychopharmacol 2015; 18: 1–10.
40. Rea E, Rummel J, Schmidt TT, Hadar R, Heinz A, Mathe AA et al. Anti-anhedonic effect of deep brain stimulation of the prefrontal cortex and the dopaminergic reward system in a genetic rat model of depression: an intracranial self-stimulation paradigm study. Brain Stimul 2014; 7: 21–28.
41. Jimenez-Vasquez PA, Diaz-Cabiale Z, Caberlotto L, Bellido I, Overstreet D, Fuxe K et al. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothala-mus of Flinders Sensitive Line rat model of depression. Eur Neuropsychopharmacol 2007; 17: 298–308.
42. Bjornebekk A, Mathé AA, Brene S. The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int J Neuropsychopharmacol 2005; 8: 357–368.
43. Strenn N, Suchankova P, Nilsson S, Fischer C, Wegener G, Mathé AA et al. Expression of inflammatory markers in a genetic rodent model of depression. Behav Brain Res 2015; 281: 348–357.
44. Carboni L, Becchi S, Piubelli C, Mallei A, Giambelli R, Razzoli M et al. Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 1037–1048.
45. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 1966; 13: 655–669.
46. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007; 8: R19.
47. Lindfors C, Nilsson IA, Garcia-Roves PM, Zuberi AR, Karimi M, Donahue LR et al. Hypothalamic mitochondrial dysfunction associated with anorexia in the anx/ anx mouse. Proc Natl Acad Sci USA 2011; 108: 18108–18113.
48. Melas PA, Lennartsson A, Vakifahmetoglu-Norberg H, Wei Y, Aberg E, Werme M et al. Allele-specific programming of Npy and epigenetic effects of physical activity in a genetic model of depression. Transl Psychiatry 2013; 3: e255.
49. O'Hara SP, Splinter PL, Gajdos GB, Trussoni CE, Fernandez-Zapico ME, Chen XM et al. NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection. J Biol Chem 2010; 285: 216–225.
50. Zhao C, Sun G, Ye P, Li S, Shi Y. MicroRNA let-7d regulates the TLX/microRNA-9 cascade to control neural cell fate and neurogenesis. Sci Rep 2013; 3: 1329.
51. He M, Liu Y, Wang X, Zhang MQ, Hannon GJ, Huang ZJ. Cell-type-based analysis of microRNA profiles in the mouse brain. Neuron 2012; 73: 35–48.
52. Shinohara Y, Yahagi K, Kawano M, Nishiyori H, Kawazu C, Suzuki N et al. miRNA profiling of bilateral rat hippocampal CA3 by deep sequencing. Biochem Biophys Res Commun 2011; 409: 293–298.
53. Meerson A, Cacheaux L, Goosens KA, Sapolsky RM, Soreq H, Kaufer D. Changes in brain MicroRNAs contribute to cholinergic stress reactions. J Mol Neurosci 2010; 40: 47–55.
54. Sangiao-Alvarellos S, Manfredi-Lozano M, Ruiz-Pino F, Navarro VM, Sanchez-Garrido MA, Leon S et al. Changes in hypothalamic expression of the Lin28/let-7 system and related microRNAs during postnatal maturation and after experimental manipulations of puberty. Endocrinology 2013; 154: 942–955.
55. Hayashi Y, Tsujii M, Wang J, Kondo J, Akasaka T, Jin Y et al. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut 2013; 62: 1536–1546.
56. Smalheiser NR, Lugli G, Rizavi HS, Torvik VI, Turecki G, Dwivedi Y. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One 2012; 7: e33201.
57. Cosin-Tomas M, Alvarez-Lopez MJ, Sanchez-Roige S, Lalanza JF, Bayod S, Sanfeliu C et al. Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise. Front Aging Neurosci 2014; 6: 51.
58. Smalheiser NR, Zhang H, Dwivedi Y. Enoxacin elevates MicroRNA levels in rat frontal cortex and prevents learned helplessness. Front Psychiatry 2014; 5: 6.
59. Bocchio-Chiavetto L, Maffioletti E, Bettinsoli P, Giovannini C, Bignotti S, Tardito D et al. Blood microRNA changes in depressed patients during antidepressant treatment. Eur Neuropsychopharmacol 2013; 23: 602–611.
60. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006; 9: 519–525.
61. Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E Jr., Janowsky DS et al. Antidepressant effects of nicotine in an animal model of depression. Psycho-pharmacology 1999; 142: 193–199.
62. Fujii YX, Fujigaya H, Moriwaki Y, Misawa H, Kasahara T, Grando SA et al. Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. J Neu-roimmunol 2007; 189: 69–74.
63. Sihotang K, Overstreet DH. Studies of a possible relationship of brain proteins to changes in behavioral sensitivity to DFP. Life Sci 1983; 32: 413–420.
64. Overstreet DH, Russell RW, Crocker AD, Schiller GD. Selective breeding for differences in cholinergic function: pre-and postsynaptic mechanisms involved in sensitivity to the anticholinesterase, DFP. Brain Res 1984; 294: 327–332.
65. Sailaja BS, Cohen-Carmon D, Zimmerman G, Soreq H, Meshorer E. Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4. Proc Natl Acad Sci USA 2012; 109: E3687–E3695.
66. Hansson AC, Rimondini R, Heilig M, Mathe AA, Sommer WH. Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats. J Psychopharmacol 2011; 25: 1378–1387.
67. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993; 23: 2375–2378.
68. Schobitz B, de Kloet ER, Sutanto W, Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci 1993; 5: 1426–1435.
69. Ni J, Wang X, Chen S, Liu H, Wang Y, Xu X et al. MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Brain Behav Immun 2015; 49: 75–85.